BIOMAT Database Logo BIOMAT Database Logo

[Effectiveness of thyrocalcitonin in parodontosis]. 1975

A I Briskin, and Zh O Oganesian

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010510 Periodontal Diseases Pathological processes involving the PERIODONTIUM including the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, and the PERIODONTAL LIGAMENT. Parodontosis,Pyorrhea Alveolaris,Disease, Periodontal,Diseases, Periodontal,Parodontoses,Periodontal Disease
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A I Briskin, and Zh O Oganesian
[Use of thyrocalcitonin in treating parodontosis].
January 1976, Stomatologiia,
A I Briskin, and Zh O Oganesian
[The effectiveness of operative treatment of parodontosis].
January 1970, Stomatologiia,
A I Briskin, and Zh O Oganesian
[Effectiveness of thyrocalcitonin in the treatment of steroid-induced osteoporosis].
November 1976, Klinicheskaia meditsina,
A I Briskin, and Zh O Oganesian
[Parodontosis].
January 1953, Revue de stomatologie,
A I Briskin, and Zh O Oganesian
[Parodontosis in diabetes].
April 1951, Deutsche zahnarztliche Zeitschrift,
A I Briskin, and Zh O Oganesian
Effectiveness of thyrocalcitonin in maintaining bone strength in vivo under decalcifying conditions.
September 1968, Aerospace medicine,
A I Briskin, and Zh O Oganesian
[Hydrofangotherapy of parodontosis].
August 1974, Voenno-meditsinskii zhurnal,
A I Briskin, and Zh O Oganesian
[Thyrocalcitonin. II. Structure of alpha-thyrocalcitonin].
May 1968, Helvetica chimica acta,
A I Briskin, and Zh O Oganesian
[Thyrocalcitonin. 3. The synthesis of alpha-thyrocalcitonin].
May 1968, Helvetica chimica acta,
A I Briskin, and Zh O Oganesian
[Parodontosis and prophylaxis].
April 1950, Paradentologie,
Copied contents to your clipboard!